Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
---|---|---|---|---|---|---|---|
Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
Ardelyx Inc. | 2 | 0 | 0 | 0 | €8.51 | €11.00 | 29.229% |
Chromadex Corp | 10 | 2 | 1 | 0 | €3.50 | €5.76 | 64.469% |
Pfizer Inc. | 31 | 4 | 3 | 1 | €26.18 | €41.10 | 57.002% |
Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.65 | €1.65 | 0.000% |
Evolus Inc | 7 | 0 | 2 | 0 | €12.20 | €20.26 | 66.028% |
UnitedHealth Group Inc. | 33 | 1 | 5 | 0 | €459.10 | €543.72 | 18.432% |
Immunic Inc. | 6 | 3 | 0 | 2 | €1.25 | €5.48 | 337.145% |
Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
Dexcom Inc. | 18 | 0 | 2 | 0 | €120.42 | €136.82 | 13.621% |
Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |
Valneva SE | 2 | 0 | 0 | 0 | €3.45 | €7.00 | 103.016% |
Exact Sciences | 11 | 0 | 0 | 0 | €58.86 | €83.49 | 41.853% |
Krystal Biotech | 17 | 0 | 4 | 0 | €145.55 | €179.60 | 23.391% |
Medpace Holdings Inc | 9 | 0 | 3 | 0 | €372.00 | €421.61 | 13.335% |
Novocure Ltd | 1 | 1 | 0 | 0 | €14.45 | - | - |
Dentsply Sirona Inc. | 13 | 0 | 3 | 0 | €26.24 | €37.86 | 44.297% |
Stoke Therapeutics Inc | 14 | 1 | 2 | 0 | €11.20 | €20.74 | 85.174% |
Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.90 | €25.20 | 95.371% |
Personalis Inc | 6 | 0 | 2 | 0 | €1.50 | €3.24 | 116.640% |
XOMA Corp. | 6 | 0 | 3 | 0 | €22.80 | €68.78 | 201.664% |
Paul Hartmann AG | 3 | 0 | 0 | 0 | €204.00 | - | - |
Madrigal Pharmaceuticals inc. | 4 | 0 | 1 | 0 | €219.00 | €315.00 | 43.836% |
Ensign Group Inc. | 9 | 0 | 2 | 0 | €109.00 | €116.99 | 7.332% |
Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |